Get Real Time Here
| Open2.790 | Close2.865 |
| Vol / Avg.16.785K / 81.641K | Mkt Cap4.849M |
| Day Range2.710 - 2.970 | 52 Wk Range2.665 - 66.000 |
Sonnet BioTherapeutics Stock (NASDAQ:SONN), Quotes and News Summary
Sonnet BioTherapeutics Stock (NASDAQ: SONN) stock price, news, charts, stock research, profile.
| Open2.790 | Close2.865 |
| Vol / Avg.16.785K / 81.641K | Mkt Cap4.849M |
| Day Range2.710 - 2.970 | 52 Wk Range2.665 - 66.000 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -6.820 | -2.860 | 3.9600 | ||||
| REV | 36.850K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-23 | EF Hutton | Michael King | Assumes | Buy | Announces | - | 6.70 |
| 2023-08-16 | Chardan Capital | Keay Nakae | Maintains | BuyBuy | Lowers | 14.00 | 12.00 |
| 2023-06-26 | EF Hutton | Michael King | Reiterates | BuyBuy | Maintains | - | 6.70 |
| 2023-05-25 | EF Hutton | Michael King | Assumes | Buy | Announces | - | 6.70 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SONN | Sonnet BioTherapeutics | -2.12% | 4.8M |
| QNRX | Quoin Pharmaceuticals | -3.06% | 4.1M |
| SNPX | Synaptogenix | 5.03% | 4.3M |
| ADXN | Addex Therapeutics | 3.54% | 6.1M |
| CYCC | Cyclacel Pharmaceuticals | -5.9% | 4.1M |
How do I buy Sonnet BioTherapeutics (SONN) stock?
You can purchase shares of Sonnet BioTherapeutics (NASDAQ: SONN) through any online brokerage.
Who are Sonnet BioTherapeutics's (SONN) competitors?
Other companies in Sonnet BioTherapeutics’s space includes: Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX), Addex Therapeutics (NASDAQ:ADXN), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and NexImmune (NASDAQ:NEXI).
What is the target price for Sonnet BioTherapeutics (SONN) stock?
The latest price target for Sonnet BioTherapeutics (NASDAQ: SONN) was reported by EF Hutton on Wednesday, August 23, 2023. The analyst firm set a price target for 6.70 expecting SONN to rise to within 12 months (a possible 141.88% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Sonnet BioTherapeutics (SONN)?
The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $2.77 last updated September 28, 2023 at 8:22 PM UTC.
Does Sonnet BioTherapeutics (SONN) pay a dividend?
There is no dividend information for Sonnet BioTherapeutics.
When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?
Sonnet BioTherapeutics’s Q4 earnings are confirmed for Thursday, December 14, 2023.
Is Sonnet BioTherapeutics (SONN) going to split?
There is no upcoming split for Sonnet BioTherapeutics.
What sector and industry does Sonnet BioTherapeutics (SONN) operate in?
Sonnet BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sonnet BioTherapeutics Stock (NASDAQ:SONN), Quotes and News Summary
Sonnet BioTherapeutics Stock (NASDAQ: SONN) stock price, news, charts, stock research, profile.
| Open2.790 | Close2.865 |
| Vol / Avg.16.785K / 81.641K | Mkt Cap4.849M |
| Day Range2.710 - 2.970 | 52 Wk Range2.665 - 66.000 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -6.820 | -2.860 | 3.9600 | ||||
| REV | 36.850K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-23 | EF Hutton | Michael King | Assumes | Buy | Announces | - | 6.70 |
| 2023-08-16 | Chardan Capital | Keay Nakae | Maintains | BuyBuy | Lowers | 14.00 | 12.00 |
| 2023-06-26 | EF Hutton | Michael King | Reiterates | BuyBuy | Maintains | - | 6.70 |
| 2023-05-25 | EF Hutton | Michael King | Assumes | Buy | Announces | - | 6.70 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SONN | Sonnet BioTherapeutics | -2.12% | 4.8M |
| QNRX | Quoin Pharmaceuticals | -3.06% | 4.1M |
| SNPX | Synaptogenix | 5.03% | 4.3M |
| ADXN | Addex Therapeutics | 3.54% | 6.1M |
| CYCC | Cyclacel Pharmaceuticals | -5.9% | 4.1M |
How do I buy Sonnet BioTherapeutics (SONN) stock?
You can purchase shares of Sonnet BioTherapeutics (NASDAQ: SONN) through any online brokerage.
Who are Sonnet BioTherapeutics's (SONN) competitors?
Other companies in Sonnet BioTherapeutics’s space includes: Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX), Addex Therapeutics (NASDAQ:ADXN), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and NexImmune (NASDAQ:NEXI).
What is the target price for Sonnet BioTherapeutics (SONN) stock?
The latest price target for Sonnet BioTherapeutics (NASDAQ: SONN) was reported by EF Hutton on Wednesday, August 23, 2023. The analyst firm set a price target for 6.70 expecting SONN to rise to within 12 months (a possible 141.88% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Sonnet BioTherapeutics (SONN)?
The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $2.77 last updated September 28, 2023 at 8:22 PM UTC.
Does Sonnet BioTherapeutics (SONN) pay a dividend?
There is no dividend information for Sonnet BioTherapeutics.
When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?
Sonnet BioTherapeutics’s Q4 earnings are confirmed for Thursday, December 14, 2023.
Is Sonnet BioTherapeutics (SONN) going to split?
There is no upcoming split for Sonnet BioTherapeutics.
What sector and industry does Sonnet BioTherapeutics (SONN) operate in?
Sonnet BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sonnet BioTherapeutics Stock (NASDAQ:SONN), Quotes and News Summary
Sonnet BioTherapeutics Stock (NASDAQ: SONN) stock price, news, charts, stock research, profile.
| Open2.790 | Close2.865 |
| Vol / Avg.16.785K / 81.641K | Mkt Cap4.849M |
| Day Range2.710 - 2.970 | 52 Wk Range2.665 - 66.000 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -6.820 | -2.860 | 3.9600 | ||||
| REV | 36.850K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-23 | EF Hutton | Michael King | Assumes | Buy | Announces | - | 6.70 |
| 2023-08-16 | Chardan Capital | Keay Nakae | Maintains | BuyBuy | Lowers | 14.00 | 12.00 |
| 2023-06-26 | EF Hutton | Michael King | Reiterates | BuyBuy | Maintains | - | 6.70 |
| 2023-05-25 | EF Hutton | Michael King | Assumes | Buy | Announces | - | 6.70 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SONN | Sonnet BioTherapeutics | -2.12% | 4.8M |
| QNRX | Quoin Pharmaceuticals | -3.06% | 4.1M |
| SNPX | Synaptogenix | 5.03% | 4.3M |
| ADXN | Addex Therapeutics | 3.54% | 6.1M |
| CYCC | Cyclacel Pharmaceuticals | -5.9% | 4.1M |
How do I buy Sonnet BioTherapeutics (SONN) stock?
You can purchase shares of Sonnet BioTherapeutics (NASDAQ: SONN) through any online brokerage.
Who are Sonnet BioTherapeutics's (SONN) competitors?
Other companies in Sonnet BioTherapeutics’s space includes: Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX), Addex Therapeutics (NASDAQ:ADXN), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and NexImmune (NASDAQ:NEXI).
What is the target price for Sonnet BioTherapeutics (SONN) stock?
The latest price target for Sonnet BioTherapeutics (NASDAQ: SONN) was reported by EF Hutton on Wednesday, August 23, 2023. The analyst firm set a price target for 6.70 expecting SONN to rise to within 12 months (a possible 141.88% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Sonnet BioTherapeutics (SONN)?
The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $2.77 last updated September 28, 2023 at 8:22 PM UTC.
Does Sonnet BioTherapeutics (SONN) pay a dividend?
There is no dividend information for Sonnet BioTherapeutics.
When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?
Sonnet BioTherapeutics’s Q4 earnings are confirmed for Thursday, December 14, 2023.
Is Sonnet BioTherapeutics (SONN) going to split?
There is no upcoming split for Sonnet BioTherapeutics.
What sector and industry does Sonnet BioTherapeutics (SONN) operate in?
Sonnet BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sonnet BioTherapeutics Stock (NASDAQ:SONN), Quotes and News Summary
Sonnet BioTherapeutics Stock (NASDAQ: SONN) stock price, news, charts, stock research, profile.
| Open2.790 | Close2.865 |
| Vol / Avg.16.785K / 81.641K | Mkt Cap4.849M |
| Day Range2.710 - 2.970 | 52 Wk Range2.665 - 66.000 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -6.820 | -2.860 | 3.9600 | ||||
| REV | 36.850K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-23 | EF Hutton | Michael King | Assumes | Buy | Announces | - | 6.70 |
| 2023-08-16 | Chardan Capital | Keay Nakae | Maintains | BuyBuy | Lowers | 14.00 | 12.00 |
| 2023-06-26 | EF Hutton | Michael King | Reiterates | BuyBuy | Maintains | - | 6.70 |
| 2023-05-25 | EF Hutton | Michael King | Assumes | Buy | Announces | - | 6.70 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SONN | Sonnet BioTherapeutics | -2.12% | 4.8M |
| QNRX | Quoin Pharmaceuticals | -3.06% | 4.1M |
| SNPX | Synaptogenix | 5.03% | 4.3M |
| ADXN | Addex Therapeutics | 3.54% | 6.1M |
| CYCC | Cyclacel Pharmaceuticals | -5.9% | 4.1M |
How do I buy Sonnet BioTherapeutics (SONN) stock?
You can purchase shares of Sonnet BioTherapeutics (NASDAQ: SONN) through any online brokerage.
Who are Sonnet BioTherapeutics's (SONN) competitors?
Other companies in Sonnet BioTherapeutics’s space includes: Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX), Addex Therapeutics (NASDAQ:ADXN), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and NexImmune (NASDAQ:NEXI).
What is the target price for Sonnet BioTherapeutics (SONN) stock?
The latest price target for Sonnet BioTherapeutics (NASDAQ: SONN) was reported by EF Hutton on Wednesday, August 23, 2023. The analyst firm set a price target for 6.70 expecting SONN to rise to within 12 months (a possible 141.88% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Sonnet BioTherapeutics (SONN)?
The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $2.77 last updated September 28, 2023 at 8:22 PM UTC.
Does Sonnet BioTherapeutics (SONN) pay a dividend?
There is no dividend information for Sonnet BioTherapeutics.
When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?
Sonnet BioTherapeutics’s Q4 earnings are confirmed for Thursday, December 14, 2023.
Is Sonnet BioTherapeutics (SONN) going to split?
There is no upcoming split for Sonnet BioTherapeutics.
What sector and industry does Sonnet BioTherapeutics (SONN) operate in?
Sonnet BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sonnet BioTherapeutics Stock (NASDAQ:SONN), Quotes and News Summary
Sonnet BioTherapeutics Stock (NASDAQ: SONN) stock price, news, charts, stock research, profile.
| Open2.790 | Close2.865 |
| Vol / Avg.16.785K / 81.641K | Mkt Cap4.849M |
| Day Range2.710 - 2.970 | 52 Wk Range2.665 - 66.000 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -6.820 | -2.860 | 3.9600 | ||||
| REV | 36.850K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-23 | EF Hutton | Michael King | Assumes | Buy | Announces | - | 6.70 |
| 2023-08-16 | Chardan Capital | Keay Nakae | Maintains | BuyBuy | Lowers | 14.00 | 12.00 |
| 2023-06-26 | EF Hutton | Michael King | Reiterates | BuyBuy | Maintains | - | 6.70 |
| 2023-05-25 | EF Hutton | Michael King | Assumes | Buy | Announces | - | 6.70 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SONN | Sonnet BioTherapeutics | -2.12% | 4.8M |
| QNRX | Quoin Pharmaceuticals | -3.06% | 4.1M |
| SNPX | Synaptogenix | 5.03% | 4.3M |
| ADXN | Addex Therapeutics | 3.54% | 6.1M |
| CYCC | Cyclacel Pharmaceuticals | -5.9% | 4.1M |
How do I buy Sonnet BioTherapeutics (SONN) stock?
You can purchase shares of Sonnet BioTherapeutics (NASDAQ: SONN) through any online brokerage.
Who are Sonnet BioTherapeutics's (SONN) competitors?
Other companies in Sonnet BioTherapeutics’s space includes: Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX), Addex Therapeutics (NASDAQ:ADXN), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and NexImmune (NASDAQ:NEXI).
What is the target price for Sonnet BioTherapeutics (SONN) stock?
The latest price target for Sonnet BioTherapeutics (NASDAQ: SONN) was reported by EF Hutton on Wednesday, August 23, 2023. The analyst firm set a price target for 6.70 expecting SONN to rise to within 12 months (a possible 141.88% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Sonnet BioTherapeutics (SONN)?
The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $2.77 last updated September 28, 2023 at 8:22 PM UTC.
Does Sonnet BioTherapeutics (SONN) pay a dividend?
There is no dividend information for Sonnet BioTherapeutics.
When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?
Sonnet BioTherapeutics’s Q4 earnings are confirmed for Thursday, December 14, 2023.
Is Sonnet BioTherapeutics (SONN) going to split?
There is no upcoming split for Sonnet BioTherapeutics.
What sector and industry does Sonnet BioTherapeutics (SONN) operate in?
Sonnet BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sonnet BioTherapeutics Stock (NASDAQ:SONN), Quotes and News Summary
Sonnet BioTherapeutics Stock (NASDAQ: SONN) stock price, news, charts, stock research, profile.
| Open2.790 | Close2.865 |
| Vol / Avg.16.785K / 81.641K | Mkt Cap4.849M |
| Day Range2.710 - 2.970 | 52 Wk Range2.665 - 66.000 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -6.820 | -2.860 | 3.9600 | ||||
| REV | 36.850K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-23 | EF Hutton | Michael King | Assumes | Buy | Announces | - | 6.70 |
| 2023-08-16 | Chardan Capital | Keay Nakae | Maintains | BuyBuy | Lowers | 14.00 | 12.00 |
| 2023-06-26 | EF Hutton | Michael King | Reiterates | BuyBuy | Maintains | - | 6.70 |
| 2023-05-25 | EF Hutton | Michael King | Assumes | Buy | Announces | - | 6.70 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SONN | Sonnet BioTherapeutics | -2.12% | 4.8M |
| QNRX | Quoin Pharmaceuticals | -3.06% | 4.1M |
| SNPX | Synaptogenix | 5.03% | 4.3M |
| ADXN | Addex Therapeutics | 3.54% | 6.1M |
| CYCC | Cyclacel Pharmaceuticals | -5.9% | 4.1M |
How do I buy Sonnet BioTherapeutics (SONN) stock?
You can purchase shares of Sonnet BioTherapeutics (NASDAQ: SONN) through any online brokerage.
Who are Sonnet BioTherapeutics's (SONN) competitors?
Other companies in Sonnet BioTherapeutics’s space includes: Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX), Addex Therapeutics (NASDAQ:ADXN), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and NexImmune (NASDAQ:NEXI).
What is the target price for Sonnet BioTherapeutics (SONN) stock?
The latest price target for Sonnet BioTherapeutics (NASDAQ: SONN) was reported by EF Hutton on Wednesday, August 23, 2023. The analyst firm set a price target for 6.70 expecting SONN to rise to within 12 months (a possible 141.88% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Sonnet BioTherapeutics (SONN)?
The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $2.77 last updated September 28, 2023 at 8:22 PM UTC.
Does Sonnet BioTherapeutics (SONN) pay a dividend?
There is no dividend information for Sonnet BioTherapeutics.
When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?
Sonnet BioTherapeutics’s Q4 earnings are confirmed for Thursday, December 14, 2023.
Is Sonnet BioTherapeutics (SONN) going to split?
There is no upcoming split for Sonnet BioTherapeutics.
What sector and industry does Sonnet BioTherapeutics (SONN) operate in?
Sonnet BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sonnet BioTherapeutics Stock (NASDAQ:SONN), Quotes and News Summary
Sonnet BioTherapeutics Stock (NASDAQ: SONN) stock price, news, charts, stock research, profile.
| Open2.790 | Close2.865 |
| Vol / Avg.16.785K / 81.641K | Mkt Cap4.849M |
| Day Range2.710 - 2.970 | 52 Wk Range2.665 - 66.000 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -6.820 | -2.860 | 3.9600 | ||||
| REV | 36.850K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-23 | EF Hutton | Michael King | Assumes | Buy | Announces | - | 6.70 |
| 2023-08-16 | Chardan Capital | Keay Nakae | Maintains | BuyBuy | Lowers | 14.00 | 12.00 |
| 2023-06-26 | EF Hutton | Michael King | Reiterates | BuyBuy | Maintains | - | 6.70 |
| 2023-05-25 | EF Hutton | Michael King | Assumes | Buy | Announces | - | 6.70 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SONN | Sonnet BioTherapeutics | -2.12% | 4.8M |
| QNRX | Quoin Pharmaceuticals | -3.06% | 4.1M |
| SNPX | Synaptogenix | 5.03% | 4.3M |
| ADXN | Addex Therapeutics | 3.54% | 6.1M |
| CYCC | Cyclacel Pharmaceuticals | -5.9% | 4.1M |
How do I buy Sonnet BioTherapeutics (SONN) stock?
You can purchase shares of Sonnet BioTherapeutics (NASDAQ: SONN) through any online brokerage.
Who are Sonnet BioTherapeutics's (SONN) competitors?
Other companies in Sonnet BioTherapeutics’s space includes: Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX), Addex Therapeutics (NASDAQ:ADXN), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and NexImmune (NASDAQ:NEXI).
What is the target price for Sonnet BioTherapeutics (SONN) stock?
The latest price target for Sonnet BioTherapeutics (NASDAQ: SONN) was reported by EF Hutton on Wednesday, August 23, 2023. The analyst firm set a price target for 6.70 expecting SONN to rise to within 12 months (a possible 141.88% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Sonnet BioTherapeutics (SONN)?
The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $2.77 last updated September 28, 2023 at 8:22 PM UTC.
Does Sonnet BioTherapeutics (SONN) pay a dividend?
There is no dividend information for Sonnet BioTherapeutics.
When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?
Sonnet BioTherapeutics’s Q4 earnings are confirmed for Thursday, December 14, 2023.
Is Sonnet BioTherapeutics (SONN) going to split?
There is no upcoming split for Sonnet BioTherapeutics.
What sector and industry does Sonnet BioTherapeutics (SONN) operate in?
Sonnet BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sonnet BioTherapeutics Stock (NASDAQ:SONN), Quotes and News Summary
Sonnet BioTherapeutics Stock (NASDAQ: SONN) stock price, news, charts, stock research, profile.
| Open2.790 | Close2.865 |
| Vol / Avg.16.785K / 81.641K | Mkt Cap4.849M |
| Day Range2.710 - 2.970 | 52 Wk Range2.665 - 66.000 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -6.820 | -2.860 | 3.9600 | ||||
| REV | 36.850K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-23 | EF Hutton | Michael King | Assumes | Buy | Announces | - | 6.70 |
| 2023-08-16 | Chardan Capital | Keay Nakae | Maintains | BuyBuy | Lowers | 14.00 | 12.00 |
| 2023-06-26 | EF Hutton | Michael King | Reiterates | BuyBuy | Maintains | - | 6.70 |
| 2023-05-25 | EF Hutton | Michael King | Assumes | Buy | Announces | - | 6.70 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SONN | Sonnet BioTherapeutics | -2.12% | 4.8M |
| QNRX | Quoin Pharmaceuticals | -3.06% | 4.1M |
| SNPX | Synaptogenix | 5.03% | 4.3M |
| ADXN | Addex Therapeutics | 3.54% | 6.1M |
| CYCC | Cyclacel Pharmaceuticals | -5.9% | 4.1M |
How do I buy Sonnet BioTherapeutics (SONN) stock?
You can purchase shares of Sonnet BioTherapeutics (NASDAQ: SONN) through any online brokerage.
Who are Sonnet BioTherapeutics's (SONN) competitors?
Other companies in Sonnet BioTherapeutics’s space includes: Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX), Addex Therapeutics (NASDAQ:ADXN), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and NexImmune (NASDAQ:NEXI).
What is the target price for Sonnet BioTherapeutics (SONN) stock?
The latest price target for Sonnet BioTherapeutics (NASDAQ: SONN) was reported by EF Hutton on Wednesday, August 23, 2023. The analyst firm set a price target for 6.70 expecting SONN to rise to within 12 months (a possible 141.88% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Sonnet BioTherapeutics (SONN)?
The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $2.77 last updated September 28, 2023 at 8:22 PM UTC.
Does Sonnet BioTherapeutics (SONN) pay a dividend?
There is no dividend information for Sonnet BioTherapeutics.
When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?
Sonnet BioTherapeutics’s Q4 earnings are confirmed for Thursday, December 14, 2023.
Is Sonnet BioTherapeutics (SONN) going to split?
There is no upcoming split for Sonnet BioTherapeutics.
What sector and industry does Sonnet BioTherapeutics (SONN) operate in?
Sonnet BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sonnet BioTherapeutics Stock (NASDAQ:SONN), Quotes and News Summary
Sonnet BioTherapeutics Stock (NASDAQ: SONN) stock price, news, charts, stock research, profile.
| Open2.790 | Close2.865 |
| Vol / Avg.16.785K / 81.641K | Mkt Cap4.849M |
| Day Range2.710 - 2.970 | 52 Wk Range2.665 - 66.000 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -6.820 | -2.860 | 3.9600 | ||||
| REV | 36.850K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-23 | EF Hutton | Michael King | Assumes | Buy | Announces | - | 6.70 |
| 2023-08-16 | Chardan Capital | Keay Nakae | Maintains | BuyBuy | Lowers | 14.00 | 12.00 |
| 2023-06-26 | EF Hutton | Michael King | Reiterates | BuyBuy | Maintains | - | 6.70 |
| 2023-05-25 | EF Hutton | Michael King | Assumes | Buy | Announces | - | 6.70 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SONN | Sonnet BioTherapeutics | -2.12% | 4.8M |
| QNRX | Quoin Pharmaceuticals | -3.06% | 4.1M |
| SNPX | Synaptogenix | 5.03% | 4.3M |
| ADXN | Addex Therapeutics | 3.54% | 6.1M |
| CYCC | Cyclacel Pharmaceuticals | -5.9% | 4.1M |
How do I buy Sonnet BioTherapeutics (SONN) stock?
You can purchase shares of Sonnet BioTherapeutics (NASDAQ: SONN) through any online brokerage.
Who are Sonnet BioTherapeutics's (SONN) competitors?
Other companies in Sonnet BioTherapeutics’s space includes: Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX), Addex Therapeutics (NASDAQ:ADXN), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and NexImmune (NASDAQ:NEXI).
What is the target price for Sonnet BioTherapeutics (SONN) stock?
The latest price target for Sonnet BioTherapeutics (NASDAQ: SONN) was reported by EF Hutton on Wednesday, August 23, 2023. The analyst firm set a price target for 6.70 expecting SONN to rise to within 12 months (a possible 141.88% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Sonnet BioTherapeutics (SONN)?
The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $2.77 last updated September 28, 2023 at 8:22 PM UTC.
Does Sonnet BioTherapeutics (SONN) pay a dividend?
There is no dividend information for Sonnet BioTherapeutics.
When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?
Sonnet BioTherapeutics’s Q4 earnings are confirmed for Thursday, December 14, 2023.
Is Sonnet BioTherapeutics (SONN) going to split?
There is no upcoming split for Sonnet BioTherapeutics.
What sector and industry does Sonnet BioTherapeutics (SONN) operate in?
Sonnet BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.